123.95
price down icon1.54%   -1.94
 
loading

Finanzdaten der Genedx Holdings Corp-Aktie (WGS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
17.88%
102.69
87.11 95.64 76.87 70.51
Cost Of Revenue
11.00%
31.79
28.64 29.43 29.05 27.56
Gross Profit
21.25%
70.90
58.48 66.20 47.83 42.95
Operating Expenses
1.72%
61.94
63.03 57.40 55.61 53.53
Benefits Costs and Expenses
1.15%
92.13
93.20 90.23 85.23 99.88
Costs And Expenses
1.15%
92.13
93.20 90.23 85.23 99.88
Operating Income/Loss
296.88%
8.96
-4.551 8.806 -7.78 -10.58
Nonoperating Income/Loss
204.70%
1.603
-1.531 -3.392 -0.579 -18.78
Income/Loss From Continuing Operations Before Tax
273.68%
10.56
-6.082 5.414 -8.359 -29.36
Income Tax Expense/Benefit
155.03%
-0.246
0.447 -0.024 -0.047 -0.19
Income/Loss From Continuing Operations After Tax
265.55%
10.81
-6.529 5.438 -8.312 -29.17
Net Income/Loss
265.55%
10.81
-6.529 5.438 -8.312 -29.17
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.53%
28.58
28.15 0.2973 27.10 26.62
Diluted Average Shares
5.71%
29.75
28.15 0.2973 27.10 26.62
Basic Earnings Per Share
265.22%
0.38
-0.23 0.23 -0.31 -1.10
Diluted Earnings Per Share
256.52%
0.36
-0.23 0.23 -0.31 -1.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research WAT
$295.39
price down icon 2.33%
diagnostics_research DGX
$182.91
price down icon 0.30%
diagnostics_research LH
$277.95
price down icon 0.63%
$168.51
price down icon 3.05%
diagnostics_research MTD
$1,259.54
price down icon 1.81%
diagnostics_research IQV
$187.22
price down icon 1.82%
Kapitalisierung:     |  Volumen (24h):